English to Russian Medical Biology (-tech,-chem,micro-)

At 21 days of administration on the human-derived lung cancer LD1-0025-361019 PDX animal model (CD74-ROS1 fusion & G2032R mutation), the tumor growth inhibition rate TGIs of Crizotinib (50 mg/kg) administration group, WX-001 high dose (20 mg/kg) administration group, WX-001 medium dose (15 mg/kg) administration group and WX-001 low dose (10 mg/kg) administration group were 35.43 %, 82.38 %, 70.03 % and 60.83 % respectively.